DeepMed Research

UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.uhhospitals.org

Clinical Trials

Surgical Theater's Surgery Rehearsal Platform

Not Applicable

Completed

Conditions: Cerebral Aneurysm Unruptured
Cerebral Aneurysm Ruptured

Interventions: Other: Control cases
Other: Active SRP cases

First Posted Date: 2014-03-28

Last Posted Date: 2017-05-05

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 40

Registration Number: NCT02099318

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States

A Concierge Model of CAE Plus LAI in Individuals With Schizophrenia at Risk for Treatment Non-adherence and Homelessness

Not Applicable

Completed

Conditions: Psychotic Disorders
Schizoaffective Disorder
Schizophrenia
Medication Adherence
Medication Non-Adherence

Interventions: Behavioral: CAE-L

First Posted Date: 2014-03-12

Last Posted Date: 2019-12-09

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 30

Registration Number: NCT02085447

Locations: 🇺🇸
University Hospitals Case Medical Center, Cleveland, Ohio, United States

Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, Ghana

Phase 3

Completed

Conditions: Onchocerciasis

Interventions: Drug: IVM
Drug: IVM plus ALB

First Posted Date: 2014-03-04

Last Posted Date: 2019-04-26

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 375

Registration Number: NCT02078024

Locations: 🇬🇭
Onchocerciasis Chemotherapy Research Centre, (OCRC) Municipal Hospital, Hohoe, Ghana

IL-17 Neutrophils in CF Lung Inflammation

Completed

Conditions: Cystic Fibrosis

First Posted Date: 2014-01-01

Last Posted Date: 2019-02-15

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 14

Registration Number: NCT02025829

Locations: 🇺🇸
Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States

Laser Spot Treatment of Perioral Rhytids

Not Applicable

Completed

Conditions: Facial Aging

Interventions: Procedure: Laser Treatment

First Posted Date: 2013-11-18

Last Posted Date: 2023-07-05

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 30

Registration Number: NCT01986634

Locations: 🇺🇸
Univeristy Hospitals Cedar Brainard Office, Lyndhurst, Ohio, United States

DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty

Phase 2

Terminated

Conditions: Postoperative Ecchymosis

Interventions: Drug: DDAVP

First Posted Date: 2013-11-13

Last Posted Date: 2023-08-16

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 14

Registration Number: NCT01982760

Locations: 🇺🇸
Lyndhurst Surgery Center, Lyndhurst, Ohio, United States

Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of Africa

Phase 2

Completed

Conditions: Lymphatic Filariasis

Interventions: Drug: Diethylcarbamazine
Drug: Albendazole
Drug: Ivermectin

First Posted Date: 2013-11-03

Last Posted Date: 2018-10-09

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 182

Registration Number: NCT01975441

Locations: 🇵🇬
Papua New Guinean Institute for Medical Research, Maprik, East Sepik, Papua New Guinea

Nebulized Hypertonic Saline for Mechanically Ventilated Children

Phase 1

Completed

Conditions: Respiratory Failure

Interventions: Drug: Placebo (0.9% saline)
Drug: Hypertonic saline (3%)

First Posted Date: 2013-09-19

Last Posted Date: 2016-06-28

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 18

Registration Number: NCT01945944

Locations: 🇺🇸
Rainbow Babies and Children's Hospital (of Univ. Hospitals Case Med. Center), Cleveland, Ohio, United States

Efficacy, Safety Study and Benefit of Alkali Therapy in Sickle Cell Disease

Phase 1

Terminated

Conditions: Metabolic Acidosis
Chronic Kidney Disease
Sickle Cell Anemia

Interventions: Drug: Sodium Bicarbonate

First Posted Date: 2013-07-10

Last Posted Date: 2019-03-20

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 7

Registration Number: NCT01894594

Locations: 🇺🇸
University hospitals Case Medical Center, Cleveland, Ohio, United States

Exhaled Carbon Monoxide as a Marker of Hemolysis in Sickle Cell Disease- an Exploratory Study

Withdrawn

Conditions: Sickle Cell Disease

First Posted Date: 2013-06-28

Last Posted Date: 2016-12-23

Lead Sponsor: University Hospitals Cleveland Medical Center

Registration Number: NCT01888614

Locations: 🇺🇸
Seidman Cancer Center, University Hospitals, Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy